For this week's discussion, I found the article by Zabalegi to be one that is super impactful. The need to put healthcare at its center, at a time when it's needed most is super important. I feel what made this article so impactful was the open letter. This letter was a call to action for those who need to support putting health care first for those around them. It seemed that there was a political push from those who wrote this letter, which makes this letter more of a concern when dealing with the health and well-being of others. This letter called for direct action from neighboring governments to build a foundation to help with the care of people who need it.
Aside from what the article discussed, I think this was a very useful way of building awareness for something that needs to change. The best way to inform others is to create a plan to communicate with those who can assist in this movement. Zabalegi said, "We do not speak here just to explain our current social condition vis-a-vis care. Our intention is not to hinder this situation without critique, but we must express our concern about some of the measures that are being taken, as we believe that they may aggravate this crisis (Zabalegi 2020)." This quote from the open letter shows that they want to help cultivate change during health care crisis's, such as COVID. The open communication this letter had was a starter in growing a conversation.
Zabalegi, Maite. “A COMMUNIQUE FROM BASQUE COUNTRY IN THE TIME OF CORONAVIRUS.” Academia.edu, https://sonoma.academia.edu/brookelober.
This comment has been removed by the author.
ReplyDeleteThis is usually done in studies that primarily study male patients. Women have been and often are excluded from studies, and women are extremely underrepresented in clinical trials. This difference between the sexes in clinical studies stems in part from the early misconception that men and women are the same. We now know this to be false; men and women are unique at the cellular level. As a result, they respond differently to drugs and medical therapies. However, early researchers were not aware of these differences and preferred to work with male test subjects for two main reasons. As a nation, we have made progress, but there is still work to be done. Clinical trials need to broaden their subject base and better represent all affected parties in order to achieve parity and generate more rational and insightful data. Patients and healthcare professionals need great transparency and "accurate information about the medical products available to them. Without data on the benefits and risks specific to a person's race, ethnicity, gender or age, how can a physician make safe decisions for her patients?
ReplyDelete